Orchid Pharma Q3 Results

  • BSE: 524372
  • NSE: ORCHPHARMA
  • ISIN: INE191A01027
  • Sector: Biotechnology & Drugs
BSE
1,508.2549.15 (3.37%)
Volume16.46 K
Updated: Mon 25 Nov, 2024 | 15:55:26
NSE
1,510.5552.20 (3.58%)
Volume96.54 K
Updated: Mon 25 Nov, 2024 | 15:29:57
Today: 1,449.85
1,522.40
52-Wk: 529.95
1,591.55

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Orchid Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 220.59198.76-%159.76-%
    Selling/ General/ Admin Expenses Total 19.1417.56-%16.68-%
    Depreciation/ Amortization 9.277.84-%8.18-%
    Other Operating Expenses Total 44.1235.55-%33.82-%
    Total Operating Expense 194.47183.28-%154.28-%
    Operating Income 26.1215.47-%5.48-%
    Net Income Before Taxes 30.1920.02-%6.73-%
    Net Income 29.4319.80-%7.59-%
    Diluted Normalized EPS 6.184.30-%1.86-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts